Evotec Investor Presentation Deck

evotec Todays use of AI/ML Significant improvements of PoS are possible How we can improve PoS in early R&D (Examples/simplified) Target identification System biology to better understand diseases e.g. associating existing targets with new diseases Lead optimisation In silico classification of targets via computational chemistry e.g. better prioritised drugs accelerated PAGE 11 Trial design Understanding sub populations via biomarkers e.g. better patient stratification Data integration in % d... 21... ..... 08. *... 20 *98* ~10% Pos up .. Integrated drug design .... .. ...... @ .*.*** 9. e bes 20. 8. at 88 Ⓒ... @ ***** tonce. ****** ... ****... *8? 100.. @* ** ~10% ... a Efficacy & safety predictions ~10% iPSC driven disease relevance ~10% Molecular data & patient stratification 'Standard' success for discovery project Data aggregation

View entire presentation